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Abstract 
The insertion of prosthetic devices into the oral cavity affects the oral microflora and 
results in accumulation of microorganisms on the prosthetic surface. Such fouling of 
denture surfaces can lead to a number of oral diseases and consequently to the 
replacement of the denture. Here, we report the post-synthesis introduction of silver in 
zeolite-loaded dental acrylic (DAZ) resins that does not influence the mechanical or 
aesthetic properties of the DA resins, and provides them with a long-term antimicrobial 
activity. Na-FAU zeolite (2 wt%) was incorporated into DA resin, which was 
conventionally processed and cut into 10 mm x 20 mm x 3 mm coupons. The Na+ in the 
zeolite was then exchanged with Ag+ via immersion of the DAZ coupons in 0.01 M 
AgNO3 solution to obtain DAZ/Ag-treated coupons used in antimicrobial tests. 
Antimicrobial tests showed that the DAZ/Ag-treated coupons were active against 
Candida albicans (a reference and a clinically relevant strain), Streptococcus mutans 
and Fusobacterium nucleatum. Ag leaching tests on the Ag-charged coupons at 1, 2, 3, 
4, 7, 14, 30 and 45 days of incubation in distilled water at 37 °C, indicated sustained 
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release of silver. Antimicrobial tests using a reference Candida albicans strain showed 
that the leached coupons retained antimicrobial activity after 45 days immersion in 
distilled water, but, after 60 days incubation no antimicrobial activity was observed. 
Cytotoxicity assay results indicated that the DAZ/Ag-treated coupons showed no 
additional cytotoxicity compared to neat dental acrylic coupons. 
Keywords: Dental acrylic resins, Zeolites, Ag ion-exchange, Long-term antimicrobial 
dentures, Candida albicans 
 
3 
 
1. Introduction 
Oral diseases such as dental caries, periodontal diseases and oral candidosis 
cause significant health problems [1,2]. Management of oral candidosis is limited due to 
the low number of antifungal drugs available, their relatively high toxicity and the 
emergence of antifungal resistance [3,4]. Non-rigorous denture hygiene facilitates 
biofilm build up and initiates local inflammatory responses in the palatal mucosa [5,6]. 
The denture itself affects salivary flow and allows more niches for microorganisms to 
flourish, co-aggregate and form biofilms, leading to malodor and a potential reservoir of 
respiratory pathogens with an increased risk of pulmonary infections [7-10]. It has been 
estimated that by 2025, in the EU alone, 53% of the population will be over 65 years of 
age, resulting in significant challenges for oral healthcare delivery [11]. An increasing 
elderly population will lead to increased demand for dentures. Thus, it would be 
worthwhile to develop methods for fabrication of dentures that contain controlled 
release antimicrobials to address the above-mentioned problems. 
Heat-cured dental acrylic resin is composed of powder and liquid components 
(typical ratio; ca. 2.5:1.0 by mass powder to liquid) [12]. The powder component 
consists of polymethylmethacylate (PMMA) suspension polymer powder, with 
accessible dibenzoyl peroxide (DBP) initiator; aesthetics related additives such as 
pigments, opacifiers and flock fibres are also added. Depending on the mode of 
manufacture, the DBP present is residual from the suspension polymerization and/or is 
added along with the other additives. The liquid component is composed of inhibited 
methylmethacrylate (MMA) monomer combined with ethyleneglycoldimethacrylate 
(EGDMA) crosslinking agent (ca. 8 wt%). Due to some dissolution of the PMMA 
beads, a dough like mass is formed a short period after mixing the powder and liquid 
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components. The dough is pressed into the mold and the liquid component polymerized 
by heating the filled mold, following a carefully planned temperature program. The 
molding surface is finished using a range of abrasives and then polished. Due to the 
presence of a significant proportion of incompletely dissolved PMMA suspension 
polymer particles in a matrix that consists of a mixture of uncrosslinked (dissolved from 
the PMMA powder particles) and EGDMA crosslinked PMMA chains (from the 
polymerized liquid component), a dental acrylic surface is heterogeneous in nature even 
before exposed pigment/opacifier particles and flock fibers are considered. The 
maximum water sorption permissible of dental acrylic according to BS EN ISO 20795-
1:2013 is 32 µg mm3 which translates to about 2.7 wt% according to Kusy et al. [13]. 
Cast acrylic sheet has water sorption values reported to be between 0.2 wt% and 2 wt% 
after very long exposure periods (Perspex design guide, Darwen, UK). The 
heterogeneous surface of dental acrylic combined with the relatively high water sorption 
therefore renders it more vulnerable to surface fouling by microbial species than cast 
acrylic sheet. These conditions enable the growth of Candida which is adept at adhering 
and forming a biofilm [5,14]. The Candida genus, and C. albicans in particular, plays a 
very important part in biofilm formation and denture stomatitis, however, bacteria also 
coexist within denture biofilms [9, 15-20]. Streptococcus mutans (S. mutans) and 
Fusobacterium nucleatum (F. nucleatum) have been found in denture biofilms [9], 
making them relevant to studies of antimicrobial dental materials. 
Zeolites are microporous aluminosilicate materials with regular pore structures 
and high surface areas, which can slowly release pre-loaded antimicrobials over long 
periods of time [21]. Their ion-exchange properties can be used to introduce 
antimicrobial metals into zeolite-loaded dental acrylics. Silver has been selected in this 
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study because of its broad spectrum of antimicrobial activity [22,23]. The aims of the 
present work were to develop a method for fabrication of Ag-containing dental acrylic 
resins with long-term antimicrobial activity and a potential for recharging of Ag upon 
Ag depletion. 
 
2. Materials and methods 
2.1 Preparation of dental acrylics 
Dental acrylic (DA) was prepared by gently mixing 30 mL liquid component 
(Pegasus Plus Heat Cure Monomer, Davis Schottlander & Davis Ltd, UK) and 69 g 
powder component (Pegasus Plus Denture Base, pink veined, Davis Schottlander & 
Davis Ltd, UK) in a glass vacuum jar. The powder – liquid mixture was allowed to rest 
for 6-8 minutes in order to allow a fraction of the PMMA particles to dissolve in the 
MMA and so confer a dough-like consistency to the mixture. The mixture was removed 
from the jar and kneaded, and then packed into eight 10 mm x 110 mm x 3 mm molds. 
Each mold was screwed down tightly and placed in a hydraulic press, applying 150 bar 
of pressure. After quickly removing the excess acrylic, the mold was again placed in the 
hydraulic press and pressed at 200 bar pressure The molding was cured at 95 °C for 9 h 
in a dry heat-curing unit (Milnes Bros, UK). After cooling to room temperature, the 
moldings were released from the mold and cut into 10 mm x 20 mm x 3 mm coupons 
for antimicrobial tests. 
Na-FAU zeolite was prepared from a gel with the molar composition 8NaOH : 
0.2Al2O3 : 1.0SiO2 : 200H2O following the procedure described in ref. [24]. The zeolite 
was organically functionalized with 3-(trimethoxysilyl) propylmethacrylate (Alfa 
Aesar) prior to adding to the DA precursor mixture [25]. Na-FAU zeolite was mixed 
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with 10 wt% silane solution in cyclohexane at a zeolite to solution weight ratio of 1 to 
10, stirred for 30 min at room temperature, washed several times with cyclohexane and 
dried at 50 °C for 72 h. Experiments were also performed using Ag-FAU zeolite 
prepared by ion-exchange with AgNO3 solution (0.05 M AgNO3 solution added at a 
zeolite to solution weight ratio of 1 to 20, stirred for 72 h in the dark, rinsed repeatedly 
with distilled water and dried at 60 °C overnight), followed by organic functionalization 
[25]. Silane-treated Ag-FAU zeolite was added to uncured DA at 0.2, 0.4, 0.7 and 2 
wt%, whereas Na-FAU and silane-treated Na-FAU zeolite was added to uncured DA at 
2 wt% for post-synthesis silver introduction. 
Na-FAU-loaded (silane-modified Na-FAU) DA coupons were treated with 
AgNO3 solution to ion-exchange Na with Ag to obtain DAZ/Ag-treated coupons. 
Individual dental acrylic coupons were transferred into 25 mL universal bottles and 20 
mL of 0.01 M AgNO3 (AgNO3, Alfa Aesar) solution was added to each universal. The 
bottles were covered with aluminum foil, and the samples were incubated on a shaker at 
150 rpm at room temperature for 24 h. After incubation, the samples were washed 20 
times with distilled water by decanting and were dried overnight at 60 °C. Blank DA 
coupons were treated in the same way to distinguish between silver ion-exchange in the 
zeolite present in the composite and silver absorption by the DA. 
2.2. Characterization of dental acrylics 
Zeolite 10 mm x 50 mm x 2 mm test pieces were band sawn from the dental 
acrylic sheets that were prepared as previously described. The long edges of the test 
pieces were smoothed using water-cooled metallographic grinding decks fitted with 
progressively finer silicon carbide paper (240-400-600 grit). Thickness and widths of 
test pieces were measured using a digital caliper. Flexural properties (modulus and 
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strength) of DA and DA loaded with 2 wt% Na-FAU or 2 wt% 3-(trimethoxysilyl) 
propylmethacrylate-treated Na-FAU and Ag-FAU were determined using a Hounsfield 
H10KS; span was 32 mm and cross-head speed was 4 mm min-1. Flexural modulus was 
determined via linear regression of the load deflection data between limits of 0.3 and 0.8 
%, respectively. Flexural strength was the maximum flexural stress recorded. Six test 
pieces of each material were tested and the averages and standard deviations recorded. 
Statistical analysis was performed with Prism version 7 (GraphPad Software, La Jolla, 
CA, USA). One-way ANOVA followed by Tueky’s multiple comparisons test was used 
to evaluate statistical differences between the samples at 95 % confidence. 
Scanning electron analysis of DA and DAZ/Ag-treated coupons was performed 
with a Carl Zeiss Ltd 40VPSupra Scanning Electron Microscope. Coupons were 
mounted on Al stubs and coated with gold prior analysis. For cross-section images, the 
coupons were attached perpendicularly to the Al stubs with a cement glue. 
2.3.  Microorganisms 
In total, four microorganisms were used for the antimicrobial testing, namely C. 
albicans NCYC 1363, C. albicans 135BM2/94, a clinical strain isolated from a patient 
attending the dental hospital at Cardiff University (ref. [26]), S. mutans NCTC 1083 and 
F. nucleatum KS 515-14. The two C. albicans strains were grown on Sabouraud 
Dextrose Agar (SDA; Oxoid, UK) and then sub-cultured in Sabouraud Dextrose Broth 
(SAB; Oxoid, UK) for 18 h at 37 °C under aerobic conditions. S. mutans NCTC 10832 
and F. nucleatum KS 515-14 were grown on Fastidious Anaerobe agar (FAA; Lab M 
Limited, UK) containing 5-10% defibrinated horse blood (TCS Biosciences Ltd, UK) 
and then sub-cultured in Fastidious Anaerobe broth (FAB; Lab M Limited, UK) at 37 
°C under anaerobic conditions. 
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2.4. Antimicrobial testing 
Antimicrobial tests were performed as described in our previous work [25]. 
Single colonies of C. albicans NCYC 1363 and C. albicans 135BM2/94 were sub-
cultured from SDA in sterile SAB. The broth was incubated for 18 h at 37 °C on an 
orbital shaker (New Brunswick Scientific, UK; I-26 model) at 150 rpm. The liquid 
culture was centrifuged at 3000 rpm (1721g; Sigma 3-16L model, UK) for 10 min. 
Afterwards, the supernatant was discarded and the pellet re-suspended in sterile ¼ 
Ringer’s solution (Oxoid, UK). An optical density of 1.0 at 540 nm was obtained 
(Jenway 6305 Spectrophotometer, UK), equaling approximately 107 CFU mL-1. A 1:100 
dilution was performed in Ringer’s solution and the suspension (approximately. 105 
CFU mL-1) was used to inoculate the dental acrylic surfaces, which were laid flat in 
individual Petri dishes. 50 µL of the standardized suspension (C. albicans NCYC 1363, 
5x105 CFU mL-1; C. albicans 135 BM2/94, 10x105 CFU mL-1; F. nucleatum KS 515-
14, 5x105 CFU mL-1; and S. mutans NCTC 10832, 3x106 CFU mL-1) was pipetted onto 
each coupon’s surface and a 20 mm x 10 mm polyethylene film was gently pressed on 
top of the droplet to ensure the cell suspension were spread evenly on the surface. 
Immediately after inoculation, three coupons were placed individually into 10 mL 
neutralizing agent (14.6% sodium thiosulphate and 10% sodium thioglycolate in 100 
mL distilled water; 5 mL was filter sterilized into 495 mL sterile distilled water) and 
vortexed for 30 s. Serial dilutions were prepared and 100 μL aliquots were spread onto 
SAB agar plates, incubated at 37 °C overnight and the CFU counted. The remaining 
coupons in petri dishes were incubated at 37 °C and tested as above after 1 and 5 h. S. 
mutans NCTC 10832 and F. nucleatum KS 515-14 were cultured under anaerobic 
conditions. The agar plates for the CFU counting of F. nucleatum KS 515-14 were 
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incubated for 48 h. The tests were carried out in triplicate and experiments were 
repeated three times. The coupons tested were DA, DA treated with AgNO3 solution 
(DA/Ag-treated) and Na-FAU (silane-modified)-loaded (2 wt%) DA after treatment 
with AgNO3 solution (DAZ/Ag-treated). 
2.5.  Cytotoxicity assay method 
Immortalized human hepatic stellate cells (Lx-2 cells developed by Scott 
Friedman, Mount Sinai, NYC, ref. [27]) were cultured in monolayer at 5% CO2 and 37 
°C in Dulbecco's modified Eagle's medium plus L-glutamine, Na-pyruvate, and 
antibiotics supplemented with 10% fetal bovine serum. For experiments, Lx-2 cells 
were plated in 6 well plates in serum-free conditions, in the presence of DA or 
DAZ/Ag-treated coupons for 48 h. Media was then recovered and incubated for 1 h at 
37 °C with MTT (EMD Millipore, Billerica, MA), a colorimetric assay used to assess 
cytotoxicity of potentially toxic materials [28]. Purple formazan crystals, formed by 
active mitochondrial enzymes, were dissolved in 0.04 N HCl in isopropanol (Fisher) 
and the intensity measured at 560 nm (n = 3 experiments), with sterile growth media 
used as a blank measure. 
2.6. Ag release experiments 
Initial Ag leaching experiments were performed with DA/Ag-treated and 
DAZ/Ag-treated coupons, to distinguish between Ag, which remains adsorbed on / 
absorbed into dental acrylics after sample preparation, and Ag, which is ion-exchanged 
within the zeolite. Nine coupons of each type of sample were placed into universal 
bottles containing 20 mL sterile distilled water, and incubated at 37 °C on a rotary 
shaker at 150 rpm. Coupons were transferred to fresh bottles with 20 mL sterile distilled 
water after 1, 2, 3, 4 and 7 days. All universal bottles were stored at -20 °C prior to 
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measurement of the Ag concentration using a Thermo Scientific iCAP6300 Duo 
inductively coupled plasma optical emission spectrometer (ICP-OES, Thermo 
Scientific, UK). Long-term silver release experiments using DAZ/Ag-treated coupons 
(in triplicate) were performed similarly; samples were taken after 1, 2, 3, 4, 7, 14, 30 
and 45 days. To detect possible microbial contamination, a loop of sample was 
inoculated every 48 h onto sterile Tryptone Soya agar plates (Oxoid, UK) and incubated 
at 37 °C for 18-24 h. The coupons were tested against C.albicans NCYC 1363 as 
described above after 45 and 60 d of the Ag leaching experiments. 
 
3. Results and discussion 
Initially, DA was loaded with silane-treated Ag-FAU. However, these samples 
showed a brown coloration, which became more intense with increased loading of Ag-
FAU (Fig. 1a). For dental applications, such a color change is unacceptable. This 
formation of dark coloration indicates that the Ag+ had undergone reduction to 
elemental silver during free radical addition polymerization of the MMA. Similar 
results were observed in our previous work for Ag-FAU-loaded silicone elastomers 
[25]. Visual inspection indicated that post-fabrication treatment with silver nitrate of 
DA and Na-FAU-loaded DA coupons did not result in such color change and that the 
“natural” color of the DA coupons was thus retained (Fig. 1b). In addition, SEM 
analysis showed that the loading of zeolite-embedded silver did not significantly change 
the DA surface morphology (Supporting information, Fig. S1)  
The characteristics of the Na-FAU and Ag-FAU zeolite used in this work have 
been discussed in detail in our previous publication [25]. The zeolite functionalization 
with silane was found to result in reduced zeolite aggregation and improved filler-
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matrix adhesion. Flexural modulus and flexural strength obtained for DA (control DA), 
DA loaded with Na-FAU (zeolite DA), DA loaded with silane-treated Na-FAU 
(Zeolite-silane DA) and DA loaded with silane-treated Ag-FAU (Ag zeolite-silane DA) 
are presented in Table 1. Addition of the unmodified zeolite (Na-FAU) and silane-
treated Na-FAU had no statistically significant effect on flexural modulus, relative to 
the control DA. However, silane treatment of Na-FAU lead to a statistically significant 
(P=0.003) increase in flexural modulus relative to untreated Na-FAU, thus supporting 
an increase in filler – matrix adhesion. Interestingly, addition of silane-treated Ag-FAU 
to DA led to a significant increase in flexural modulus, relative to the control DA (P < 
0.0001) and to silane-treated Na-FAU (P=0.02). The latter may indicate that Ag-FAU 
may interact more prolifically with the silane than Na-FAU, leading to further increased 
filler – matrix adhesion. Addition of all types of zeolite led to reductions in flexural 
strength relative to the control DA. This was most likely due to incomplete dispersion of 
the zeolites. In all cases, however, the measured properties satisfied BS EN ISO 20795-
1:2013, which specifies that flexural modulus of denture base acrylic must not be lower 
than 2 GPa and flexural strength not lower than 65 MPa. 
Initial antimicrobial tests using the reference C. albicans strain showed that the 
DA/Ag-treated and DAZ/Ag-treated samples had similar antimicrobial activity 
(Supporting information, Fig. S2). This indicated that silver was released from both the 
zeolite-free and the zeolite-loaded dental acrylics, resulting in an antimicrobial activity. 
Short-term silver leaching experiments were performed to determine a procedure for the 
removal of the ‘non-zeolitic’ silver from DA prior to testing. The results in Supporting 
information, Fig. S3, showed that the adsorbed silver was removed after 2 d of 
incubation in distilled water. The antimicrobial test using a 2 d-leached sample 
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(Supporting information, Fig. S4) confirmed this conclusion and the DA/Ag-treated in 
this case did not kill C. albicans after 1 and 5 h of incubation. Further antimicrobial 
tests were performed after 2 d immersion of the DA/Ag-treated and DAZ/Ag-treated 
coupons in distilled water. 
The antimicrobial activity of the post molding Ag-charged Na-FAU-loaded DA 
(DAZ/Ag-treated) coupons against the two strains of C. albicans as well as S. mutans 
and F. nucleatum are shown in Fig. 2. DAZ/Ag-treated coupons showed antimicrobial 
activity against C. albicans NCYC 1363 (Fig. 2a, 3-log reduction in microbial counts 
after 5 h of incubation), C. albicans 135BM2/94 (Fig. 2b, 3-log reduction in microbial 
counts after 5 h of incubation), S. mutans (Fig. 2c, 4-log reduction in bacterial counts 
after 5 h of incubation) and F. nucleatum (Fig. 2d, 3-log reduction in bacterial counts 
after 5 h of incubation). In all cases, the DA and DA/Ag-treated coupons did not show 
activity against the selected microorganisms in the tests. 
Cell viability tests were performed to assess the biocompatibility of the 
DAZ/Ag-treated samples. Absorbance measured using the MTT assay is an indicator of 
mitochondrial enzyme activity. There was no significant difference between the DA and 
DAZ/Ag-treated (Fig. 3). Therefore, compared to DA, DAZ/Ag-treated does not 
demonstrate any additional cytotoxicity. 
Long-term silver leaching experiments were performed to determine the 
antimicrobial lifetime of the DAZ/Ag-treated coupons. The results shown in Fig. 4 
indicate that there was a sustained Ag release over the time period studied (45 d), 
although the concentration of released Ag gradually decreased from 1.89 ppm (after 1 d 
of incubation) to 0.12 ppm (after 45 d of incubation). Owing to the significance of 
Candida in causing denture stomatitis [4], this microorganism was used to determine 
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the long-term antimicrobial activity of DAZ/Ag-treated samples. The antimicrobial tests 
against C. albicans 135 BM2/94 performed after 45 d of leaching showed that the 
antimicrobial activity of DAZ/Ag-treated coupons was retained (Fig. 5). However, the 
activity was lost after 60 d of leaching indicating that Ag recharging would be needed 
after ca. 45 d to restore the antimicrobial activity of DAZ/Ag-treated (Fig. 5).  
The treatment of denture-related stomatitis involves a range of different 
approaches such as antifungal therapy (both systemic and topical application), use of 
disinfectants and cleansers, laser treatment of palatal tissue, ongoing oral hygiene 
protocols for patients, denture replacement, placement of a resilient liner or a tissue 
conditioner and microwave disinfection [29]. This multi-modal approach aims to 
eliminate pathogenic microorganisms and prevent/disrupt biofilm formation. Figueiral 
et al. have shown in their pilot study that antifungal therapy in isolation did not 
eliminate denture stomatitis [30]. Treatment of patients with fluconazole resulted in 
some healing and reduced denture stomatitis symptoms, but the improvement was short 
lived; after a 6 month follow-up the severity of the condition had returned to pre-
treatment levels. Furthermore, patients had developed a certain level of antimicrobial 
resistance to fluconazole. A more elegant approach to prevent denture stomatitis is to 
incorporate antimicrobials into denture base materials [31], or to functionalize such 
materials in order to increase drug binding capacity [32]. Silver has been used for 
centuries for its antimicrobial effect in different fields of medicine [14,33]. Previous 
studies using PMMA-silver nanoparticle discs on NIH-3T3 mouse embryonic 
fibroblasts and a Jurkat human lymphocyte cell line have shown that metabolism and 
proliferation have not been affected [34] and that silver does not present a threat to 
human health [14]. However, drawbacks associated with the use of silver nanoparticles 
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and other silver-based materials include nanoparticle aggregation and deterioration of 
composite mechanical properties, aesthetic incompatibility due to color changes 
resulting from reduction of Ag+ to Ag0 and short-term antimicrobial activity [35,36]. 
Further critical considerations include long-term studies, which typically include reports 
of the antimicrobial activity after up to 28 d without precise determination of the 
antimicrobial lifetime of the dental materials [37,38]. The possibility to recharge the 
antimicrobial agent into the denture material has also rarely been demonstrated [39]. 
The present study addresses many of the above problems. A novel method for 
post-fabrication charging of silver was developed through utilization of the ion-
exchange capacity of a zeolite, which has been loaded into dental acrylic resins prior to 
curing. As this method eliminates the risk of Ag+ reduction during acrylic 
polymerization, the tendency to develop coloration in dental acrylic resins was also 
eliminated to the extent that post-fabrication charging did not affect visually the color of 
the material. Charging of silver can be potentially repeated after silver depletion by 
immersion in silver nitrate solution, thus providing a restoration of antimicrobial 
activity and possibly significantly extended denture lifetime. The flexural strength and 
flexural modulus requirements for denture base acrylics of the zeolite-loaded DA were 
still met. Finally, the zeolite-loaded DA did not demonstrate additional cytotoxicity 
compared to neat DA. 
In terms of antimicrobial properties, DAZ/Ag-treated samples showed consistent 
activity against a reference and a clinical strain of C. albicans as well as S. mutans and 
F. nucleatum. This activity can be attributed to the silver ions released from the 
DAZ/Ag-treated coupons. The silver release experiments revealed that during the first 
two days of leaching the silver came in to solution via two routes; the rapid reduction in 
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silver concentration was due to depletion of silver that was adsorbed within the DA 
resin matrix coupled with the more sustained release of silver from the zeolite particles. 
The latter zeolite-related mode of silver delivery continued far beyond two days. The 
DAZ/Ag-treated coupons were soaked in sterile distilled water for 2 d prior to tests in 
order to ensure that the silver came only from the zeolite. However, for practical 
applications, this is not necessary and DAZ/Ag-treated samples can be used 
immediately after preparation. Further, the 45 d silver release experiments and the 
antimicrobial tests indicated that the antimicrobial lifetime of the DA materials with 
respect to C. albicans was about 45 d, during which their antimicrobial potential 
remained constant, although activity was lost after 60 d.  
The results presented are significant in terms of the development of a procedure 
for modifying denture base materials with potentially rechargeable antimicrobial silver 
by simple AgNO3 treatment. Oral health is a problem affecting a large proportion of the 
ever-increasing elderly population [9]. It is important to highlight that there is a 
systematic link between oral health and other diseases such as cardiovascular diseases 
[40], kidney diseases [41], and pulmonary diseases [42], and therefore a management 
strategy on how to combat oral health, including denture stomatitis, is of utmost 
importance. This study shows that addition of Ag to PMMA inhibits the growth of 
potential pathogenic oral microorganisms (bacteria and fungi) and could be used for 
management of oral health in patients with dentures.  
Future developments of this study would include testing of single species 
biofilm assays on DAZ/Ag-treated coupons, tests using physiological conditions such as 
artificial saliva, and tests against a consortium of oral microorganisms associated with 
denture plaque. Charging of silver can be potentially repeated after silver depletion, thus 
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providing a restoration of antimicrobial activity and possibly significantly extended 
denture lifetime. Determination of the number of cycles this can be done without 
affecting performance would be worth studying.  
4. Conclusion 
A method was developed to prepare silver-containing dental acrylic resins with 
antimicrobial activity against fungi (clinical and reference strains of C. albicans) and 
bacteria (S. mutans and F. nucleatum). The method involved fabrication of Na-zeolite-
loaded (silane-modified Na-FAU zeolite, 2 wt%) DA test pieces followed by treatment 
with a 0.01 M AgNO3 solution to exchange the Na zeolite counter-ions with silver. The 
Ag-charging did not affect visually the aesthetic appearance of the denture base 
materials, whereas the mechanical properties of the zeolite-loaded resins were within 
the standard requirements for such materials. The antimicrobial activity was associated 
with the sustained release of Ag from the materials. Antimicrobial tests of leached 
samples against C. albicans showed that the materials retained their activity for at least 
45 d, however the activity was lost after 60 d of incubation in distilled water. 
Cytotoxicity assay indicated that the introduction of Ag into DA did not result into 
additional cytotoxicity compared to neat DA. Considering the long-term antimicrobial 
activity of the Ag-charged dental acrylic resins containing zeolite, the potential for and 
the ease of silver recharging, the mechanical and color retention properties of the acrylic 
resins as well as the importance of silver as antimicrobial agent, the materials developed 
would be of great interest for prevention of denture-related oral diseases such as denture 
stomatitis. 
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Figure captions 
Figure 1. Digital images of DA resins: (a) from left to right: DA and Ag-FAU loaded 
DA at loadings of 0.2 wt%, 0.4 wt%, 0.7 wt% and 2.0 wt%, and (b) from left to right: 
DA, DA/Ag-treated and DAZ/Ag-treated (2 wt% Na-FAU). 
 
Figure 2. Antimicrobial activity of control (DA), DA/Ag-treated and DAZ/Ag-treated 
coupons against: (a) C. albicans NCYC 1363, (b) C. albicans 135 BM2/94, (c) S. 
mutans NCTC 10832 and (d) F. nucleatum KS 515-14. 
 
 
Figure 3.  
Absorbance readings from MTT assay performed on growth media used in the culture 
of LX-2 human hepatic cells in the presence of DA or DAZ/Ag-treated. There is no 
significant difference (p>0.05) in the absorbance, demonstrating no additional 
cytotoxicity of the DAZ/Ag-treated compared to DA. n=3 independent experiments. NS 
= no significant difference. 
 
Figure 4. Concentrations of Ag released from DAZ/Ag-treated coupons over 45 days. 
 
Figure 5. Antimicrobial activity of DA coupons and DAZ/Ag-treated coupons against 
C. albicans 135 BM2/94 after 45 d and after 60 d of incubation in distilled water; the 
coupons were transferred to fresh distilled water at 1, 2, 3, 4, 7, 14, 30 and 45 d as 
described in experimental. 
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Table 1. Flexural modulus and flexural strength values obtained (standard deviations are 
in parenthesis) for control DA and DA loaded with 2 wt% zeolites: Na-FAU (Zeolite 
DA), silane-treated Na-FAU (Zeolite-silane DA) and DA loaded with silane-treated Ag-
FAU (Silver zeolite-silane DA). 
Specimen Flexural Modulus (n=6) 
(GPa) 
Flexural Strength (n=6) 
(MPa) 
Control DA 2.52 (0.10) 91.5 (1.3) 
Zeolite DA 2.45 (0.05) 84.0 (6.0) 
Zeolite-silane DA 2.65 (0.04) 87.0 (3.1) 
Ag zeolite-silane DA 2.82 (0.12) 83.3 (6.4) 
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